期刊文献+

Ipr1/PPE68穿梭质粒构建及诱导BALB/c小鼠免疫应答的探讨

Immune response induced by Ipr1/PPE68 shuttle plasmid in BALB/C mice model
下载PDF
导出
摘要 目的构建Ipr1/PPE68共表达穿梭质粒pBIPO(pBud-Ipr1-PPE68-OriM),探讨其诱导BALB/C小鼠的免疫应答特征。方法将Ipr1基因和PPE68编码序列以及结核分枝杆菌(Mycobacterium tuberculosis,MTB)的复制子OriM分别插入质粒pBudCE4.1的多克隆位点,构建共表达穿梭质粒pBIPO,经酶切测序及Western blotting鉴定后,用其免疫BALB/c小鼠,于末次免疫后2w处死小鼠,ELISA法分别检测小鼠血清中lgG2a、IL-12及IFN-γ的水平,流式细胞仪检测CD4+和CD8+T细胞数量,MTT法检测特异性脾淋巴细胞增殖,同时观察肺脾组织病理学变化。结果酶切测序鉴定PPE68和Ipr1基因序列与理论值相符,Western-blotting鉴定PPE68和Ipr1蛋白表达成功。质粒pBIPO免疫后小鼠血清中的lgG2a、IFN-γ及IL-12水平与CD4+和CD8+T细胞表达均呈现出有意义的提高,脾淋巴细胞增殖与BCG组相比差异无统计学意义,肺脾组织未见病理学改变。结论成功构建DNA疫苗(pBIPO),该疫苗能够有效诱导BALB/c小鼠的细胞免疫应答,为进一步研究其抗MTB的免疫保护作用奠定基础。 The purpose of this study was to construct an co-expression shuttle plasmid with the intracellular pathogen resistance l(Iprl) gene, the coding sequences of Pro-Pro-Glu 68(PPE68) and OriM, and study the induced immune response. Iprl genes and the coding sequences of PPE68 and OriM were cloned into the MCS sites of the plasmid pBudCE4.1. After the gene sequences and the protein expression were analyzed by restriction analysis, DNA sequencing and Western-blotting, the BALB/c mice were immunized with plasmid pBIPO. Two weeks after the last immunization, the levels of lgG2a, IL-12 and IFN-y in the serums were detected by ELISA, the quantity of CD4^+ and CD8^+ T cells were assessed with FCM, and the specif- ic spleen lymphocytes proliferations were evaluated by MTT. At the same time, pathological changes in the lungs and spleenswere investigated. The result showed that restriction analysis and DNA sequencing proved that the Iprl gene and PPE68 gene were coincided with theoretical sequences, and the results of Western-blotting showed that Iprl protein and PPE68 protein were expressed successfully. After the mice were immunized with plasmid pBIPO,the levels of lgG2a, IL-12 and IFN-7 in the serums and the quantity of CD4+ and CDS+T cells were significantly increase, spleen lymphocyte proliferative responses were no dif- ferent from BCG group,the lungs and spleens were not obviously pathological changes. This founding suggests that DNA vac- cine (pBIPO) are constructed successfully,and it could effectively induce cellular immunity in BALB/c mice. Tthis study lays a foundation for further research about immune protection efficacy of the DNA vaccine.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2012年第5期429-432,共4页 Chinese Journal of Zoonoses
基金 国家自然科学基金(No.30901280 81101216)资助
关键词 MTB Ipr1 PPE68 DNA疫苗 免疫应答 Mycobacterium tuberculosis (MTB) Iprl PPE68 DNA vaccine immune response
  • 相关文献

参考文献10

  • 1World Health Organization, Global tuberculosis control, surveil- lance, planning, financing [R/OL]. World Health Organization Report 2009 : Whole abdominal multivisceral transplantation int/ publication/global_ report / 2009/en/index. html.
  • 2Rosalind Rowland, Helen McShane. Tuberculosis vaccines in clinical trials[J]. Expert Review, 2011,10(5), 645 658.
  • 3Hue Panl, Bo-Shaun Yan, Mauricio Rojas,et al. Iprl gene me- diates innate immunity to tuberculosis [J]. NATURE, 2005, 434,767-772.
  • 4Caroline Demangel, Priscille Brodin, Paul J, et al. Culture Fil trate Protein and ESAT-6 Independently of a 10- Kilodalton RI)I Immunogenicity tuberculosis mycobacterium contributes to cell envelope proteinPPE68 [J]. Infect Immune, 2004, 72(4) :2120- 2176.
  • 5靳志栋,张丹,何永林,徐蕾,佘茜,张壮苗,杨春.PPE68/Ipr1真核共表达质粒的构建及鉴定[J].中国生物制品学杂志,2011,24(4):410-413. 被引量:3
  • 6Masaji okada, Yoko Kita. Tuberculosis vaccine development= the development of novel (preclinical) DNA vaccine [J]. Human Vaccines, 2010, 6:4, 297 308.
  • 7Bryce M, Buddle D, Neil Wedlock, et al. Update on vaccination of cattle and wildlife populations against tuberculosis [J] Veter- inary Microbiology, 2011, 151 : 14-22.
  • 8Patricia Me, ndez-Samperio. Role of interleukin-12 family cyto kines in the cellular response to mycobaeterial disease[J]. Inter- national Journal of Infectious, 2010,14:366-371.
  • 9Philana Ling Lin,JoAnne L, Flynn. Understanding latent tuber- culosis: a moving target [J]. The Journal of Immunology, 2010, 185: 15-22.
  • 10Toshi Nagatal, Yukio Koide. Induction of specific CD8 +T (;ells against intracellular bacteria by CD8 + T-Cell-oriented immunization approaches [J] Journal of Biomedicine and Bio- technology, 2010 : 764542.

二级参考文献11

  • 1Young D B, Perkins M D, Duncan K, et al. Confronting the sci- entific obstacles to global control of tuberculosis [J]. J Clin In- vest, 2008, 118 (4): 1255-1265.
  • 2Yang C, He YL, Zhang L, et al. GLS/IL-12-modified Mycobac- terium smegmatis as a novel anti-tuberculosis inamunotherapeutic vaccine [J]. Int J Tuberc Lung Dis, 2009, 13 ( 11 ): 1360-1366.
  • 3Majlessi L, Brodin P, Brosch R, et al. Influence of ESAT-6 se- cretion system 1 (RDI) of Mycobacterium tuberculosis on the in- teraction between mycobacteria and the host immune system [J]. J Immunol, 2005, 174 (6): 3570-3579.
  • 4Brodin P, Majlessi L, Marsollier L, et al. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immuno- genicity and virulence [J]. Infect Immun, 2006, 74 (1): 88-98.
  • 5Demangel C, Brodin P, Cockle PJ, et al. Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immuno- genicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 [J]. Infect Immun, 2004, 72 (4): 2170-2176.
  • 6Kramnik I, Dietrich WF, Demant P, et al. Genetic control of re- sistance to experimental infection with virulent Mycobacterium tu- berculosis [J]. Proc Natl Acad Sci USA, 2000, 97 (15): 8560- 8565.
  • 7Pan H, Yan BS, Rojas M, et al. Ipr1 gene mediates innate immu- nity to tuberculosis [J]. Nature, 2005, 434 (7034): 767-772.
  • 8Kramnik I. Genetic dissection of host resistance to Mycobacterium tuberculosis: the sstl locus and the Ipr1 gene [J]. Curr Top Mi- crobiol Immunol, 2008, 321 (1): 123-148.
  • 9Thye T, Browne EN, Chinbuah MA, et al. No associations of hu- man pulmonary tuberculosis with Sp110 variants [J]. J Med Genet, 2006, 43 (7): e32.
  • 10Mustaia AS, Al-Attiyah R, Hanif SN, et al. Efficient testing of large pools of Mycobacterium tuberculosis RDI peptides and i- dentification of major antigens and immunodominant peptides recognized by human Th1 cells [J]. Clin Vaccine Immunol, 2008, 15 (6): 916-924.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部